| COMPOSITION | |
|---|---|
| K-MET 500 mg Tablets | |
| Each Uncoated Sustained Release Tablet Contains: | |
| Metformin Hydrochloride IP | 500 mg |
| K-MET 1000 mg Tablets | |
| Each Uncoated Sustained Release Tablet Contains: | |
| Metformin Hydrochloride IP | 1000 mg |
| INDICATIONS | |
| In non-obese type 2 diabetes mellitus not adequately controlled with sulphonylureas. Obese type 2 diabetes mellitus not controlled by weight reduction and dietary modification. | |
| DOSAGE AND ADMINISTRATION | |
| Oral: Adults: One tablet to be taken once dialy with breakfast. Maximum dose for Metformin:2 gram daily in divided doses. | |
| HOW SUPPLIED | |
| 10 Tablets per strip. | |
